Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma
Abstract Thioredoxin1 (TRX1) and telomerase are both attractive oncology targets that are tightly implicated in tumor initiation and development. Here, we reported that the 6-dithio-2-deoxyguanosine analog thiotert exhibits an effective cytotoxic effect on myelodysplastic syndromes (MDS) cell SKM-1...
Saved in:
Main Authors: | Qiangan Jing, Yunyi Wu, Yanchun Li, Chaoting Zhou, Junyu Zhang, Jun Xia, Keyi Li, Yuhuan Shen, Hongfeng Yao, Xiangmin Tong, Jing Du, Lushan Yu, Ying Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13062-025-00594-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of thioredoxin and prochymosin coexpression on the refolding of recombinant alpaca chymosin
by: S. V. Belenkaya, et al.
Published: (2023-07-01) -
Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
by: Baobing Zhao, et al.
Published: (2019-03-01) -
Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01) -
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms
by: Esther Natalie Oliva, et al.
Published: (2025-02-01) -
Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
by: Zdenek Krejcik, et al.
Published: (2025-01-01)